Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Archives of Psychiatry and Clinical Neuroscience

• Publication date

  2013-04-12

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00406-013-0404-5PMID 23580110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive alterations in patients with non‐affective psychotic disorder and their unaffected siblings and parents

  2012cited by this paper
• Cognitive Impairments in Schizophrenia and Schizoaffective Disorder: Relationship With Clinical Characteristics

  2012cited by this paper
• The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.

  2012cited by this paper
• Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating

  2012cited by this paper
• Persistent cannabis users show neuropsychological decline from childhood to midlife

  2012cited by this paper
• Effects of δ9-tetrahydrocannabinol on human working memory function.

  2012cited by this paper
• Neuropsychological deficits associated with cannabis use in young adults.

  2012cited by this paper
• What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

  2011cited by this paper
• Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status.

  2011cited by this paper
• [Wisconsin Card Sorting Test (WCST)].

  2011cited by this paper
• Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs.

  2011cited by this paper
• Cannabis use and cognitive function: 8-year trajectory in a young adult cohort.

  2011cited by this paper
• Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis

  2011cited by this paper
• Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up.

  2011cited by this paper
• Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.

  2011cited by this paper
• Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up

  2011cited by this paper
• Cannabis use and cognitive functioning in first-episode schizophrenia patients.

  2010cited by this paper
• Cannabis and psychosis/schizophrenia: human studies

  2009cited by this paper
• The role of cannabis in cognitive functioning of patients with schizophrenia

  2009cited by this paper
• Cognitive performance and cigarette smoking in first-episode psychosis

  2009cited by this paper
• Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

  2009cited by this paper
• Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.

  2008cited by this paper
• Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations.

  2008cited by this paper
• The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls

  2008cited by this paper
• Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence

  2008cited by this paper
• Cannabis, the mind and society: the hash realities

  2007cited by this paper
• Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

  2007cited by this paper
• An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

  2006cited by this paper
• Nicotine use in schizophrenia: the self medication hypotheses.

  2005cited by this paper
• A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors.

  2005cited by this paper
• Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

  2005cited by this paper
• Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up.

  2005cited by this paper
• Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder.

  2005cited by this paper
• Neurocognitive consequences of marihuana--a comparison with pre-drug performance.

  2005cited by this paper
• Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

  2005cited by this paper
• CANTAB explicit memory is less impaired in addicted schizophrenia patients.

  2005cited by this paper
• Interleukin‐1β (IL‐1β) gene and increased risk for the depressive symptom‐dimension in schizophrenia spectrum disorders

  2004cited by this paper
• The MATRICS initiative: developing a consensus cognitive battery for clinical trials.

  2004cited by this paper
• Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders.

  2004cited by this paper
• Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort.

  2003cited by this paper
• Cognitive disparity in schizophrenics with and without cocaine dependency.

  2003cited by this paper
• Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia.

  2003cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics.

  2002cited by this paper
• Neuropsychological performance in long-term cannabis users.

  2001cited by this paper
• Wechsler Adult Intelligence Scale-III

  2001cited by this paper
• Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients.

  2000cited by this paper
• Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients.

  2000cited by this paper
• Neurocognitive Deficits in the Dually Diagnosed With Schizophrenia and Cocaine Abuse

  1999cited by this paper
• Cannabis and schizophrenia: results of a follow-up study

  1999cited by this paper
• TAVEC: test de aprendizaje verbal España-Complutense : manual

  1998cited by this paper
• A parametric study of prefrontal cortex involvement in human working memory.

  1996cited by this paper
• Cannabis abuse and the course of recent-onset schizophrenic disorders.

  1994cited by this paper
• Wisconsin Card Sorting Test Manual – Revised and Expanded

  1993cited by this paper
• The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation

  1993cited by this paper
• The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

  1992cited by this paper
• The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families.

  1988cited by this paper
• Statistical package for the social sciences (spss)

  1981cited by this paper

• Memory processes in schizophrenia: impact of comorbidity with substance use disorders.

  2025cites this paper
• The Iowa Gambling Task: Men and Women Perform Differently. A Meta-analysis

  2024cites this paper
• Impairment of social cognition in comparative studies of patients with schizophrenia and their healthy siblings.

  2023influential citation
• The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.

  2022cites this paper
• Neurocognitive correlates of the varied domains of outcomes at 20 year follow-up of first-episode psychosis.

  2022cites this paper
• Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders

  2022influential citation
• Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review.

  2021cites this paper
• References

  2020cites this paper
• The effect of the AKT1 gene and cannabis use on cognitive performance in healthy subjects

  2020cites this paper
• Cannabis, schizophrenia and cognition: the contribution of brain connectivity.

  2020cites this paper
• Childhood adversities and psychotic symptoms: The potential mediating or moderating role of neurocognition and social cognition.

  2019cites this paper
• Stopping cannabis use benefits outcome in psychosis: findings from 10‐year follow‐up study in the PAFIP‐cohort

  2019cites this paper
• Substance misuse and social cognition on the psychosis-spectrum: A bottom-up framework

  2019cites this paper
• Meta-analysis of neurocognition in young psychosis patients with current cannabis use.

  2018cites this paper
• Therapeutic potential of medicinal marijuana: an educational primer for health care professionals

  2018cites this paper
• Long‐term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings

  2018cites this paper
• The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research

  2018cites this paper
• Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis.

  2017cites this paper
• Theory of Mind Impairments in Women With Cocaine Addiction.

  2017cites this paper
• Lifetime Cannabis Use and Cognition in Psychosis Spectrum Disorders

  2017cites this paper
• The Health Effects of Cannabis and Cannabinoids : The Current State of Evidence and Recommendations for Research Committee on the Health Effects of Marijuana : An Evidence

  2017cites this paper
• The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition.

  2017cites this paper
• La cognition sociale chez les apparentés de patients atteints de schizophrénie

  2016cites this paper
• Pronóstico a largo plazo del trastorno bipolar con episodios mixtos.

  2016cites this paper
• Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis.

  2016cites this paper
• A comparative study of the working memory multicomponent model in psychosis and healthy controls.

  2015cites this paper
• Thinking Matters: The Profile of Executive Functioning Associated with Cannabis Use in Schizophrenia and its Functional Outcome Correlates

  2015cites this paper
• Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.

  2015cites this paper
• Gone to Pot – A Review of the Association between Cannabis and Psychosis

  2014cites this paper
• Therapeutic targets in major psychiatric disorders revisited

  2013cites this paper
• Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia

  2013cites this paper